Pathogenesis of HIV-associated cardiovascular complications

Giuseppe Barbaro, Stacy D. Fisher, Steven E Lipshultz

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Reviews and studies published before the introduction of highly active antiretroviral therapy (HAART) have tracked the incidence and course of HIV infection in relation to cardiac illness in both children andadults. The introduction of HAART regimens has significantly modified the course of HIV disease, with longer survival rates and improvement of life quality in HIV-infected people expected. However, early data raised concerns about HAART being associatedwith an increase in both peripheral and coronary arterial diseases. In this review we discuss HIV-associated cardiovascular complications focusingon pathogenetic mechanisms that could have a rolein diagnosis, management, and therapy of these complications in the HAART era.

Original languageEnglish
Pages (from-to)115-124
Number of pages10
JournalLancet Infectious Diseases
Volume1
Issue number2
DOIs
StatePublished - Sep 1 2001
Externally publishedYes

Fingerprint

Highly Active Antiretroviral Therapy
HIV
Peripheral Arterial Disease
HIV Infections
Coronary Disease
Survival Rate
Quality of Life
Incidence
Therapeutics

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Pathogenesis of HIV-associated cardiovascular complications. / Barbaro, Giuseppe; Fisher, Stacy D.; Lipshultz, Steven E.

In: Lancet Infectious Diseases, Vol. 1, No. 2, 01.09.2001, p. 115-124.

Research output: Contribution to journalArticle

Barbaro, Giuseppe ; Fisher, Stacy D. ; Lipshultz, Steven E. / Pathogenesis of HIV-associated cardiovascular complications. In: Lancet Infectious Diseases. 2001 ; Vol. 1, No. 2. pp. 115-124.
@article{2d2a51c5f7c84b7c96e9089d16ed92b4,
title = "Pathogenesis of HIV-associated cardiovascular complications",
abstract = "Reviews and studies published before the introduction of highly active antiretroviral therapy (HAART) have tracked the incidence and course of HIV infection in relation to cardiac illness in both children andadults. The introduction of HAART regimens has significantly modified the course of HIV disease, with longer survival rates and improvement of life quality in HIV-infected people expected. However, early data raised concerns about HAART being associatedwith an increase in both peripheral and coronary arterial diseases. In this review we discuss HIV-associated cardiovascular complications focusingon pathogenetic mechanisms that could have a rolein diagnosis, management, and therapy of these complications in the HAART era.",
author = "Giuseppe Barbaro and Fisher, {Stacy D.} and Lipshultz, {Steven E}",
year = "2001",
month = "9",
day = "1",
doi = "10.1016/S1473-3099(01)00067-6",
language = "English",
volume = "1",
pages = "115--124",
journal = "The Lancet Infectious Diseases",
issn = "1473-3099",
publisher = "Lancet Publishing Group",
number = "2",

}

TY - JOUR

T1 - Pathogenesis of HIV-associated cardiovascular complications

AU - Barbaro, Giuseppe

AU - Fisher, Stacy D.

AU - Lipshultz, Steven E

PY - 2001/9/1

Y1 - 2001/9/1

N2 - Reviews and studies published before the introduction of highly active antiretroviral therapy (HAART) have tracked the incidence and course of HIV infection in relation to cardiac illness in both children andadults. The introduction of HAART regimens has significantly modified the course of HIV disease, with longer survival rates and improvement of life quality in HIV-infected people expected. However, early data raised concerns about HAART being associatedwith an increase in both peripheral and coronary arterial diseases. In this review we discuss HIV-associated cardiovascular complications focusingon pathogenetic mechanisms that could have a rolein diagnosis, management, and therapy of these complications in the HAART era.

AB - Reviews and studies published before the introduction of highly active antiretroviral therapy (HAART) have tracked the incidence and course of HIV infection in relation to cardiac illness in both children andadults. The introduction of HAART regimens has significantly modified the course of HIV disease, with longer survival rates and improvement of life quality in HIV-infected people expected. However, early data raised concerns about HAART being associatedwith an increase in both peripheral and coronary arterial diseases. In this review we discuss HIV-associated cardiovascular complications focusingon pathogenetic mechanisms that could have a rolein diagnosis, management, and therapy of these complications in the HAART era.

UR - http://www.scopus.com/inward/record.url?scp=0035468746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035468746&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(01)00067-6

DO - 10.1016/S1473-3099(01)00067-6

M3 - Article

VL - 1

SP - 115

EP - 124

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

SN - 1473-3099

IS - 2

ER -